Clinical trialNCT01866904TerminatedObservational

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

SponsorAstraZenecaEnrollment9,284Stable Coronary Artery Disease (CAD), Myocardial Infarction

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Brieger, MBBS, PhD
Concord Repatriation General Hospital
Principal Investigator
clinicaltrials.gov ↗
Lin Zhang, M.D., PhD
AstraZeneca GMA
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

309 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Buenos Aires, Argentina
Research Site
Corrientes, Argentina
Research Site
Córdoba, Argentina
Research Site
Mendoza, Argentina
Research Site
Salta, Argentina
Research Site
Santa Fe, Argentina

Australia

Research Site
Coffs Harbour, New South Wales, Australia
Research Site
Concord, New South Wales, Australia
Research Site
Kogarh, New South Wales, Australia
Research Site
Liverpool, New South Wales, Australia
Research Site
Newcastele, New South Wales, Australia
Research Site
St Leonards, New South Wales, Australia
Research Site
Wollongong, New South Wales, Australia
Research Site
Brisbane, Queensland, Australia
Research Site
Nambour, Queensland, Australia
Research Site
Southport, Queensland, Australia
Research Site
Woolloongabba, Queensland, Australia
Research Site
Epping, Victoria, Australia
Research Site
Parkville, Victoria, Australia
Research Site
Richmond, Victoria, Australia
Research Site
Fremantle, Western Australia, Australia
Research Site
Nedlands, Western Australia, Australia

Belgium

Research Site
Aalst, Belgium
Research Site
Bonheiden, Belgium
Research Site
Brasschaat, Belgium
Research Site
Brussels, Belgium
Research Site
Genk, Belgium
Research Site
Ghent, Belgium
Research Site
Kortrijk, Belgium
Research Site
Ostend, Belgium
Research Site
Overpelt, Belgium
Research Site
Veurne, Belgium

Brazil

Research Site
Campo Grande, Mato Grosso do Sul, Brazil
Research Site
Blumenal, Santa Cantarina, Brazil
Research Site
Marília, São Paulo, Brazil
Research Site
São José do Rio Preto, São Paulo, Brazil

Canada

Research Site
Saint John, New Brunswick, Canada
Research Site
Brampton, Ontario, Canada
Research Site
Cambridge, Ontario, Canada
Research Site
Hamilton, Ontario, Canada

269 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Jun 2013
Primary completion: 31 Mar 2017
Completion: 31 Mar 2017
Last update posted: 4 Sept 2018
Registered enrollment: 9,284
Registry id: NCT01866904

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.